Europe Cellulite Treatment Market Size, Share & Trends Analysis Report By Gender (Female and Male), By Procedure Type, By Cellulite Type, By End User (Clinics & Beauty Centers, Hospitals and Others), By Country and Growth Forecast, 2024 - 2031

The Europe Cellulite Treatment Market would witness market growth of 9.9% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Cellulite Treatment Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $349.6 Million by 2031. The UK market is exhibiting a CAGR of 8.9% during (2024 - 2031). Additionally, The France market would experience a CAGR of 10.7% during (2024 - 2031).



In recent years, skincare products targeting cellulite are also gaining popularity. Some of the ingredients in these products, including caffeine, retinol, and antioxidants, claim to diminish the appearance of cellulite. Caffeine is frequently incorporated into cellulite-targeting skincare products on account of its capacity to reduce fluid retention and enhance circulation, thereby potentially aiding in the reduction of cellulite appearance. Another popular ingredient, retinol, which is a form of vitamin A, is thought to increase skin texture and stimulate collagen production, thereby diminishing the appearance of cellulite. Because they prevent skin damage and enhance general well-being, cellulite-targeting skincare products frequently incorporate antioxidants, including vitamins C and E.

Moreover, the increased prevalence of social media and influencer marketing has contributed to heightened consciousness and endorsement of skincare products that purport to diminish the visual appearance of cellulite. Additionally, the convenience and accessibility of skin care products make them a popular choice for consumers looking to address their cellulite concerns. Skincare products can be easily incorporated into a daily skincare routine and purchased over the counter or online, making them a convenient option for consumers.

The increasing demand for cellulite treatment in Europe can be linked to the high prevalence of overweight adults and physical inactivity in the region. According to Eurostat, the proportion of overweight adults in the EU varied between 37% in Italy and 58% in Croatia for women and between 53% in France and 73% in Croatia for men. Thus, the high prevalence of overweight adults and physical inactivity in Europe suggests a significant potential market for cellulite treatments.

Based on Gender, the market is segmented into Female and Male. Based on Procedure Type, the market is segmented into Non-invasive, Topical, and Minimally Invasive. Based on Cellulite Type, the market is segmented into Soft Cellulite, Hard Cellulite and Edematous. Based on End User, the market is segmented into Clinics & Beauty Centers, Hospitals and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

• Candela Corporation (Syneron Medical)
• Bausch Health Companies, Inc.
• Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
• AbbVie, Inc.
• Cynosure, LLC (Clayton, Dubilier & Rice, LLC)
• Hologic, Inc.
• Galderma S.A.
• Zimmer MedizinSysteme GmbH
• Endo International PLC
• Merz Pharma GmbH & Co. KGaA

Market Report Segmentation

By Gender

• Female
• Male

By Procedure Type

• Non-invasive
• Topical
• Minimally Invasive

By Cellulite Type

• Soft Cellulite
• Hard Cellulite
• Edematous

By End User

• Clinics & Beauty Centers
• Hospitals
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe